Ballentine Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Sell
26,982
-2,494
-8% -$12.4K ﹤0.01% 1040
2026
Q1
$136K Sell
29,476
-2,631
-8% -$13.7K ﹤0.01% 971
2025
Q4
$161K Sell
32,107
-456
-1% -$2.37K ﹤0.01% 939
2025
Q3
$165K Sell
32,563
-2,299
-7% -$10.1K ﹤0.01% 945
2025
Q2
$150K Sell
34,862
-2,306
-6% -$11.4K ﹤0.01% 910
2025
Q1
$224K Buy
37,168
+403
+1% +$2.04K ﹤0.01% 749
2024
Q4
$145K Sell
36,765
-7,282
-17% -$32.6K ﹤0.01% 812
2024
Q3
$258K Sell
44,047
-1,183
-3% -$5.83K ﹤0.01% 646
2024
Q2
$195K Buy
45,230
+12,914
+40% +$61.9K ﹤0.01% 700
2024
Q1
$152K Buy
32,316
+5,773
+22% +$22.1K ﹤0.01% 694
2023
Q4
$130K Buy
+26,543
New +$130K ﹤0.01% 646
2023
Q3
Sell
-10,293
Closed -$95.3K 637
2023
Q2
$95.3K Buy
+10,293
New +$87.1K ﹤0.01% 584

Other funds holding MPT

Ballentine Partners's MPT Position: Q2 2026 in Review

Ballentine Partners reduced its Medical Properties Trust (MPT) stake by 8.5% in Q2 2026, selling an estimated $12.4K and leaving 26,982 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #1040.

Ballentine Partners first reported a position in MPT in Q2 2023 and has held it in 12 quarters since. The position peaked at $258K in Q3 2024. 49 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Ballentine Partners held 26,982 shares of Medical Properties Trust worth $125K as of Q2 2026.
  • Ballentine Partners sold 2,494 Medical Properties Trust shares in Q2 2026, an estimated $12.4K.
  • Medical Properties Trust made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1040 holding.
  • Ballentine Partners first reported a position in Medical Properties Trust in Q2 2023 and has held it in 12 quarters since.
  • Ballentine Partners's Medical Properties Trust position peaked at $258K in Q3 2024.
  • 49 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.